Published in J Neural Transm (Vienna) on April 03, 2011
The role of oxidative stress in Parkinson's disease. J Parkinsons Dis (2013) 1.86
The link between the GBA gene and parkinsonism. Lancet Neurol (2012) 1.80
The role of alpha-synuclein in melanin synthesis in melanoma and dopaminergic neuronal cells. PLoS One (2012) 0.98
Overexpression of parkin ameliorates dopaminergic neurodegeneration induced by 1- methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. PLoS One (2012) 0.95
Bright light exposure reduces TH-positive dopamine neurons: implications of light pollution in Parkinson's disease epidemiology. Sci Rep (2013) 0.88
Melanin affinity and its possible role in neurodegeneration. J Neural Transm (Vienna) (2013) 0.86
Loss of functional alpha-synuclein: a toxic event in Parkinson's disease? J Parkinsons Dis (2012) 0.86
The contribution of alpha synuclein to neuronal survival and function - Implications for Parkinson's disease. J Neurochem (2016) 0.85
Neuromelanin, neurotransmitter status and brainstem location determine the differential vulnerability of catecholaminergic neurons to mitochondrial DNA deletions. Mol Brain (2011) 0.83
Increased α-synuclein phosphorylation and nitration in the aging primate substantia nigra. Cell Death Dis (2012) 0.82
Sirtuins and proteolytic systems: implications for pathogenesis of synucleinopathies. Biomolecules (2015) 0.78
Interaction between Neuromelanin and Alpha-Synuclein in Parkinson's Disease. Biomolecules (2015) 0.77
Post-translational modifications of α-synuclein contribute to neurodegeneration in the colon of elderly individuals. Mol Med Rep (2016) 0.75
Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science (1997) 28.30
alpha-Synuclein locus triplication causes Parkinson's disease. Science (2003) 20.20
Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet (2004) 7.69
Alpha-Synuclein is degraded by both autophagy and the proteasome. J Biol Chem (2003) 6.84
The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS (1988) 6.75
Unbiased stereological estimation of the number of neurons in the human hippocampus. J Comp Neurol (1990) 3.96
Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease. J Neurol Neurosurg Psychiatry (1997) 3.14
A role for alpha-synuclein in the regulation of dopamine biosynthesis. J Neurosci (2002) 2.37
Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease? Neurobiol Dis (2006) 2.23
Autophagic stress in neuronal injury and disease. J Neuropathol Exp Neurol (2006) 2.17
Recommendations for straightforward and rigorous methods of counting neurons based on a computer simulation approach. J Chem Neuroanat (2000) 1.82
Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles. Proc Natl Acad Sci U S A (2000) 1.81
Inflammation in Parkinson's diseases and other neurodegenerative diseases: cause and therapeutic implications. Curr Pharm Des (2007) 1.41
Age-related decreases in Nurr1 immunoreactivity in the human substantia nigra. J Comp Neurol (2002) 1.32
The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson's disease. FEBS Lett (2002) 1.22
Extensive nuclear localization of alpha-synuclein in normal rat brain neurons revealed by a novel monoclonal antibody. Neuroscience (2007) 1.21
Aging of the nigrostriatal system in the squirrel monkey. J Comp Neurol (2004) 1.20
Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease. Brain (2005) 1.12
Overexpression of human alpha-synuclein causes dopamine neuron death in primary human mesencephalic culture. Brain Res (2002) 1.06
Inhibition of tyrosine hydroxylase expression in alpha-synuclein-transfected dopaminergic neuronal cells. Neurosci Lett (2004) 1.00
Ageing of substantia nigra in humans: cell loss may be compensated by hypertrophy. Neuropathol Appl Neurobiol (2002) 0.94
Unbiased morphometrical measurements show loss of pigmented nigral neurones with ageing. Neuropathol Appl Neurobiol (1999) 0.92
Low numbers and no loss of melanized nigral neurons with increasing age in normal human brains from India. Ann Neurol (1998) 0.91
Influence of neuromelanin on oxidative pathways within the human substantia nigra. Neurotoxicol Teratol (2002) 0.90
Neuromelanin and iron in human locus coeruleus and substantia nigra during aging: consequences for neuronal vulnerability. J Neural Transm (Vienna) (2006) 0.89
Generation of reactive oxygen species by tyrosine hydroxylase: a possible contribution to the degeneration of dopaminergic neurons? J Neurochem (1997) 0.88
Silencing alpha-synuclein gene expression enhances tyrosine hydroxylase activity in MN9D cells. Neurochem Res (2008) 0.87
Evidence for specific phases in the development of human neuromelanin. Neurobiol Aging (2006) 0.84
Residual substantia nigra neuromelanin in Parkinson's disease is cross-linked to alpha-synuclein. Neurochem Int (2003) 0.83
Neuromelanin induces oxidative stress in mitochondria through release of iron: mechanism behind the inhibition of 26S proteasome. J Neural Transm (Vienna) (2005) 0.82
Neuromelanin inhibits enzymatic activity of 26S proteasome in human dopaminergic SH-SY5Y cells. J Neural Transm (Vienna) (2004) 0.81
Alpha-synuclein aggregation and neurodegenerative diseases. J Alzheimers Dis (2003) 0.79
New face of neuromelanin. J Neural Transm Suppl (2006) 0.77
The role of peroxidase in neuromelanin synthesis: a review. Physiol Chem Phys Med NMR (1997) 0.77
The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature (2002) 18.30
Regulation of Raf-1 by direct feedback phosphorylation. Mol Cell (2005) 5.88
Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program. Cancer Res (2004) 5.88
Efficacy of sunitinib and sorafenib in metastatic papillary and chromophobe renal cell carcinoma. J Clin Oncol (2008) 5.27
alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. JAMA (2002) 5.07
Human Proteinpedia enables sharing of human protein data. Nat Biotechnol (2008) 4.21
The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia. Am J Surg Pathol (2013) 3.68
Renal mass biopsy--a renaissance? J Urol (2007) 3.12
Association between genetic variation of CACNA1H and childhood absence epilepsy. Ann Neurol (2003) 2.79
An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma. Cancer Cell (2011) 2.78
Interleukin-8 mediates resistance to antiangiogenic agent sunitinib in renal cell carcinoma. Cancer Res (2010) 2.61
Regional homogeneity changes in patients with Parkinson's disease. Hum Brain Mapp (2009) 2.42
Surgical resection of renal cell carcinoma after targeted therapy. J Urol (2009) 2.29
Histone H2A.Z cooperates with RNAi and heterochromatin factors to suppress antisense RNAs. Nature (2009) 2.19
Structural and thermodynamic properties of selective ion binding in a K+ channel. PLoS Biol (2007) 2.10
Renal angiomyolipoma: clinicopathologic study of 194 cases with emphasis on the epithelioid histology and tuberous sclerosis association. Am J Surg Pathol (2009) 2.10
NIPA2 located in 15q11.2 is mutated in patients with childhood absence epilepsy. Hum Genet (2012) 2.08
TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of Caucasian, African-American and Japanese patients. Prostate (2010) 2.05
Metastatic sarcomatoid renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy. J Clin Oncol (2008) 2.00
Protein phosphatase 2A positively regulates Ras signaling by dephosphorylating KSR1 and Raf-1 on critical 14-3-3 binding sites. Curr Biol (2003) 1.98
MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis. J Clin Invest (2013) 1.89
von Hippel-Lindau gene status and response to vascular endothelial growth factor targeted therapy for metastatic clear cell renal cell carcinoma. J Urol (2008) 1.87
Renal epithelioid angiomyolipoma with atypia: a series of 40 cases with emphasis on clinicopathologic prognostic indicators of malignancy. Am J Surg Pathol (2010) 1.87
Fusion of ALK to the Ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor. Genes Chromosomes Cancer (2003) 1.86
The ubiquitin ligase gp78 promotes sarcoma metastasis by targeting KAI1 for degradation. Nat Med (2007) 1.81
Changes of functional connectivity of the motor network in the resting state in Parkinson's disease. Neurosci Lett (2009) 1.78
CK2 Is a component of the KSR1 scaffold complex that contributes to Raf kinase activation. Curr Biol (2006) 1.69
A susceptibility locus at chromosome 3p21 linked to familial nasopharyngeal carcinoma. Cancer Res (2004) 1.65
Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease. Mov Disord (2014) 1.63
Immune synapse formation requires ZAP-70 recruitment by ezrin and CD43 removal by moesin. J Cell Biol (2007) 1.61
Diverse roles of HP1 proteins in heterochromatin assembly and functions in fission yeast. Proc Natl Acad Sci U S A (2009) 1.60
microRNA-141 is involved in a nasopharyngeal carcinoma-related genes network. Carcinogenesis (2010) 1.59
Can saturation biopsy predict prostate cancer localization in radical prostatectomy specimens: a correlative study and implications for focal therapy. Urology (2010) 1.58
A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy. J Urol (2007) 1.57
Gleason 6 prostate tumors diagnosed in the PSA era do not demonstrate the capacity for metastatic spread at the time of radical prostatectomy. Urology (2013) 1.56
Clinical correlates of renal angiomyolipoma subtypes in 209 patients: classic, fat poor, tuberous sclerosis associated and epithelioid. J Urol (2008) 1.55
Expression of PTEN and mTOR in sacral chordoma and association with poor prognosis. Med Oncol (2014) 1.50
Cortisone dissociates the Shaker family K+ channels from their beta subunits. Nat Chem Biol (2008) 1.50
Modulation of voltage-dependent Shaker family potassium channels by an aldo-keto reductase. J Biol Chem (2006) 1.48
Tubulocystic carcinoma of the kidney: clinicopathologic and molecular characterization. Am J Surg Pathol (2008) 1.47
Crystal structure of a bacterial homologue of the kidney urea transporter. Nature (2009) 1.46
Stress-induced phosphorylation and proteasomal degradation of mitofusin 2 facilitates mitochondrial fragmentation and apoptosis. Mol Cell (2012) 1.46
Bilateral synchronous sporadic renal tumors: pathologic concordance and clinical implications. Urology (2011) 1.45
Effective connectivity of brain networks during self-initiated movement in Parkinson's disease. Neuroimage (2010) 1.44
Roles of DCL4 and DCL3b in rice phased small RNA biogenesis. Plant J (2011) 1.42
miR-216b suppresses tumor growth and invasion by targeting KRAS in nasopharyngeal carcinoma. J Cell Sci (2011) 1.41
Cutting edge: Ku70 is a novel cytosolic DNA sensor that induces type III rather than type I IFN. J Immunol (2011) 1.41
KSR2 is a calcineurin substrate that promotes ERK cascade activation in response to calcium signals. Mol Cell (2009) 1.39
Circulating miR-17, miR-20a, miR-29c, and miR-223 combined as non-invasive biomarkers in nasopharyngeal carcinoma. PLoS One (2012) 1.37
Intersection patterns of human coronary veins and arteries. Anat Sci Int (2008) 1.37
Paraganglioma-like dermal melanocytic tumor: a unique entity distinct from cellular blue nevus, clear cell sarcoma, and cutaneous melanoma. Am J Surg Pathol (2004) 1.36
Expression of prostate-specific membrane antigen in tumor-associated neovasculature of renal neoplasms. Urology (2007) 1.34
alpha-Methylacyl-CoA racemase: expression levels of this novel cancer biomarker depend on tumor differentiation. Am J Pathol (2002) 1.34
Cardiac-specific overexpression of fibroblast growth factor-2 protects against myocardial dysfunction and infarction in a murine model of low-flow ischemia. Circulation (2003) 1.32
Effect of SPLUNC1 protein on the Pseudomonas aeruginosa and Epstein-Barr virus. Mol Cell Biochem (2007) 1.31
Functional connectivity of cortical motor areas in the resting state in Parkinson's disease. Hum Brain Mapp (2010) 1.30
Expression of EphA2 is prognostic of disease-free interval and overall survival in surgically treated patients with renal cell carcinoma. Clin Cancer Res (2005) 1.30
Neural correlates of bimanual anti-phase and in-phase movements in Parkinson's disease. Brain (2010) 1.28
Modifications of the interactions in the motor networks when a movement becomes automatic. J Physiol (2008) 1.28
BRD7, a novel bromodomain gene, inhibits G1-S progression by transcriptionally regulating some important molecules involved in ras/MEK/ERK and Rb/E2F pathways. J Cell Physiol (2004) 1.27
Quantitative analysis along the pyramidal tract by length-normalized parameterization based on diffusion tensor tractography: application to patients with relapsing neuromyelitis optica. Neuroimage (2006) 1.27
Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer. Am J Surg Pathol (2002) 1.26
Cytogenetic and molecular cytogenetic findings in 43 aneurysmal bone cysts: aberrations of 17p mapped to 17p13.2 by fluorescence in situ hybridization. Mod Pathol (2004) 1.25
Phase II trial of neoadjuvant docetaxel before radical prostatectomy for locally advanced prostate cancer. Urology (2004) 1.25
Primary leiomyosarcoma of the kidney: a clinicopathologic study of 27 cases. Am J Surg Pathol (2010) 1.25
Crystal structure of a potassium ion transporter, TrkH. Nature (2011) 1.25
Renal neuroendocrine tumours: a clinicopathological study. BJU Int (2007) 1.24
Crystal structure of human dehydroepiandrosterone sulphotransferase in complex with substrate. Biochem J (2002) 1.23
Cancer diagnosis using proteomic patterns. Expert Rev Mol Diagn (2003) 1.23
Characterization of ETS gene aberrations in select histologic variants of prostate carcinoma. Mod Pathol (2009) 1.23
Progression and staging of Lewy pathology in brains from patients with dementia with Lewy bodies. J Neurol Sci (2002) 1.23
Clr4/Suv39 and RNA quality control factors cooperate to trigger RNAi and suppress antisense RNA. Science (2011) 1.22
Caffeine suppresses metastasis in a transgenic mouse model: a prototype molecule for prophylaxis of metastasis. Clin Exp Metastasis (2004) 1.22
Carcinoma of the collecting ducts of Bellini and renal medullary carcinoma: clinicopathologic analysis of 52 cases of rare aggressive subtypes of renal cell carcinoma with a focus on their interrelationship. Am J Surg Pathol (2012) 1.21
Adult cystic nephroma and mixed epithelial and stromal tumor of the kidney: clinical, radiographic, and pathologic characteristics. Urology (2008) 1.20
Demonstration of a role for alpha-synuclein as a functional microtubule-associated protein. J Alzheimers Dis (2004) 1.19
Mtr4-like protein coordinates nuclear RNA processing for heterochromatin assembly and for telomere maintenance. Cell (2013) 1.19
Renal medullary carcinoma: molecular, pathological and clinical evidence for treatment with topoisomerase-inhibiting therapy. BJU Int (2009) 1.18
Functional coupling between the Kv1.1 channel and aldoketoreductase Kvbeta1. J Biol Chem (2008) 1.18
Aging influence on functional connectivity of the motor network in the resting state. Neurosci Lett (2007) 1.18
Pathologic stage migration has slowed in the late PSA era. Urology (2007) 1.17
Effective connectivity of neural networks in automatic movements in Parkinson's disease. Neuroimage (2009) 1.17
Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney. Am J Surg Pathol (2010) 1.16
Regulation of microtubule-based microtubule nucleation by mammalian polo-like kinase 1. Proc Natl Acad Sci U S A (2011) 1.15
A working group classification of focal prostate atrophy lesions. Am J Surg Pathol (2006) 1.13
Identification of a novel Wnt5a-CK1ɛ-Dvl2-Plk1-mediated primary cilia disassembly pathway. EMBO J (2012) 1.13
Molecular therapy of breast cancer: progress and future directions. Nat Rev Endocrinol (2010) 1.13
Corticosterone alters AMPAR mobility and facilitates bidirectional synaptic plasticity. PLoS One (2009) 1.13
Trials of new germ cell immunohistochemical stains in 93 extragonadal and metastatic germ cell tumors. Hum Pathol (2007) 1.13
Grade-specific expression profiles of miRNAs/mRNAs and docking study in human grade I-III astrocytomas. OMICS (2011) 1.12
Normal aging decreases regional homogeneity of the motor areas in the resting state. Neurosci Lett (2007) 1.12
Structure and permeation mechanism of a mammalian urea transporter. Proc Natl Acad Sci U S A (2012) 1.11
The role of α-synuclein in neurotransmission and synaptic plasticity. J Chem Neuroanat (2010) 1.11
The transcriptional regulation role of BRD7 by binding to acetylated histone through bromodomain. J Cell Biochem (2006) 1.11
Metanephric adenoma and solid variant of papillary renal cell carcinoma: common and distinctive features. Histopathology (2013) 1.10
BRD7 suppresses the growth of Nasopharyngeal Carcinoma cells (HNE1) through negatively regulating beta-catenin and ERK pathways. Mol Cell Biochem (2007) 1.10
Second prize: preliminary experience with the Niris optical coherence tomography system during laparoscopic and robotic prostatectomy. J Endourol (2007) 1.10
Neoadjuvant docetaxel treatment for locally advanced prostate cancer: a clinicopathologic study. Cancer (2007) 1.09
Use of a novel FISH assay on paraffin-embedded tissues as an adjunct to diagnosis of alveolar rhabdomyosarcoma. Lab Invest (2006) 1.09
Enhancement of blood-brain barrier permeability and reduction of tight junction protein expression are modulated by chemokines/cytokines induced by rabies virus infection. J Virol (2014) 1.09